A retrospective study evaluating the adherence to different anti-osteoporotic medications in elderly patients following hip fracture
Latest Information Update: 30 Jun 2021
Price :
$35 *
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates; Ibandronic acid; Teriparatide; Zoledronic acid
- Indications Hip fracture; Osteoporosis
- Focus Therapeutic Use
- 30 Jun 2021 New trial record
- 01 Jun 2021 Results published in the Injury - International Journal of the Care of the Injured